Newstral
Article
The Globe and Mail on 2016-11-01 22:14
Valeant said to be in talks for sale of Salix business to Takeda
Related news
- FValeant in talks to sell Salix to Takeda for $10bnft.com
- Valeant in talks to sell Salix stomach-drug unit in $10 billion dealReuters
- FPharmaceuticals: Valeant in talks to sell Salix to Takeda for $10bnft.com
- FValeant agrees to buy Salix for $10bnft.com
- FValeant nears deal to buy Salixft.com
- FValeant shares surge 13% on Salix dealft.com
- FValeant bid knocks Endo out of Salix raceft.com
- Valeant said to secure financing for potential Salix takeoverbizjournals.com
- FValeant aims to sweeten $14.5bn Salix bidft.com
- Valeant ups Salix bid to $11.11B; Endo ends questThe Salt Lake Tribune
- Valeant agrees to buy drugmaker Salix for $10.1-billion: sourceThe Globe and Mail
- FValeant raises offer for Salixft.com
- Valeant Pharmaceuticals Corp. to invest in gastrointestinal drugmaker Salix, CEO saysbusiness.financialpost.com
- Valeant Wins Salix After Raising Offerwsj.com
- Valeant to increase its offer for Salixbizjournals.com
- Valeant Nears Deal to Buy Salixwsj.com
- Valeant looks to sell Salix, says reportbizjournals.com
- Valeant Pharmaceuticals International Inc. exploring Salix Pharmaceuticals Ltd takeover: sourcesbusiness.financialpost.com
- Valeant agrees to buy Salix for about $10 billionThe Salt Lake Tribune
- Valeant ups Salix bid to $11.11B and Endo ends questThe Fayetteville Observer